| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | JARID2 TCF7L2 PSIP1 NUP98 NUCKS1 KMT2A MLLT1 MLLT3 HES1 CHD8 CHD1 NKAP NKAPL NIPBL TOP1 | 8.39e-08 | 739 | 75 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.67e-06 | 30 | 75 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.35e-06 | 31 | 75 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.23e-05 | 206 | 75 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 6.16e-05 | 265 | 75 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NOLC1 SEPTIN8 JARID2 PSIP1 BCLAF1 PDE4DIP ZMYND8 NUP98 CIR1 NUCKS1 MLLT3 NKAP POLK NIPBL HNRNPCL3 | 1.33e-04 | 1356 | 75 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 2.07e-04 | 6 | 75 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.61e-04 | 37 | 75 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NOLC1 USP8 TCF7L2 KIF21A ZMYND8 HES1 CHD8 XPA NIPBL TOP1 HNRNPCL3 | 4.04e-04 | 875 | 75 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.55e-04 | 262 | 75 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 4.93e-04 | 9 | 75 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 6.03e-04 | 44 | 75 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.00e-03 | 753 | 75 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.14e-03 | 68 | 75 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.23e-03 | 69 | 75 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.42e-03 | 71 | 75 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.53e-03 | 20 | 75 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.85e-03 | 645 | 75 | 8 | GO:0140640 | |
| GeneOntologyMolecularFunction | helicase activity | 2.97e-03 | 158 | 75 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.77e-03 | 83 | 75 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | methylated histone binding | 4.17e-03 | 86 | 75 | 3 | GO:0035064 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 JARID2 TCF7L2 INTS12 BCLAF1 RBMX2 NUP98 KMT2A SLU7 MLLT1 MLLT3 PRPF38B CHD8 BOD1L1 XPA NIPBL HNRNPCL3 | 5.76e-06 | 1377 | 75 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 3.80e-05 | 3 | 75 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.53e-04 | 75 | 75 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | nuclear periphery | 3.76e-04 | 171 | 75 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | methyltransferase complex | 6.18e-04 | 108 | 75 | 4 | GO:0034708 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 9.66e-04 | 13 | 75 | 2 | GO:0099535 | |
| HumanPheno | Short sternum | 5.05e-07 | 13 | 28 | 4 | HP:0000879 | |
| HumanPheno | Aplasia/Hypoplasia of the sternum | 2.68e-06 | 19 | 28 | 4 | HP:0006714 | |
| HumanPheno | Pointed chin | 8.17e-05 | 138 | 28 | 6 | HP:0000307 | |
| MousePheno | small face | 2.08e-05 | 37 | 62 | 4 | MP:0030064 | |
| MousePheno | abnormal face size | 3.46e-05 | 42 | 62 | 4 | MP:0030063 | |
| MousePheno | short face | 5.40e-05 | 17 | 62 | 3 | MP:0030066 | |
| MousePheno | absent gastric milk in neonates | 8.72e-05 | 102 | 62 | 5 | MP:0009546 | |
| MousePheno | decreased rib number | 1.16e-04 | 57 | 62 | 4 | MP:0003345 | |
| MousePheno | decreased vertebrae number | 1.72e-04 | 63 | 62 | 4 | MP:0004645 | |
| Domain | SynMuv_product | 1.51e-05 | 2 | 73 | 2 | PF06047 | |
| Domain | NKAP/UPF0396 | 1.51e-05 | 2 | 73 | 2 | IPR009269 | |
| Domain | FRG2 | 4.51e-05 | 3 | 73 | 2 | PF15315 | |
| Domain | FRG2 | 4.51e-05 | 3 | 73 | 2 | IPR026245 | |
| Domain | YEATS | 9.00e-05 | 4 | 73 | 2 | IPR005033 | |
| Domain | YEATS | 9.00e-05 | 4 | 73 | 2 | PS51037 | |
| Domain | YEATS | 9.00e-05 | 4 | 73 | 2 | PF03366 | |
| Domain | AT_hook | 1.57e-04 | 27 | 73 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.57e-04 | 27 | 73 | 3 | IPR017956 | |
| Domain | PHD | 2.12e-04 | 75 | 73 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 2.59e-04 | 79 | 73 | 4 | IPR019787 | |
| Domain | SNF2_N | 2.62e-04 | 32 | 73 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.62e-04 | 32 | 73 | 3 | PF00176 | |
| Domain | Znf_FYVE_PHD | 2.76e-04 | 147 | 73 | 5 | IPR011011 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.43e-04 | 35 | 73 | 3 | IPR002464 | |
| Domain | PHD | 4.08e-04 | 89 | 73 | 4 | SM00249 | |
| Domain | DEAH_ATP_HELICASE | 4.38e-04 | 38 | 73 | 3 | PS00690 | |
| Domain | Znf_PHD | 4.44e-04 | 91 | 73 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.23e-04 | 95 | 73 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.44e-04 | 96 | 73 | 4 | PS01359 | |
| Domain | BROMODOMAIN_2 | 5.49e-04 | 41 | 73 | 3 | PS50014 | |
| Domain | BROMO | 5.89e-04 | 42 | 73 | 3 | SM00297 | |
| Domain | Bromodomain | 5.89e-04 | 42 | 73 | 3 | IPR001487 | |
| Domain | - | 5.89e-04 | 42 | 73 | 3 | 1.20.920.10 | |
| Domain | Helicase_C | 8.18e-04 | 107 | 73 | 4 | PF00271 | |
| Domain | HELICc | 8.18e-04 | 107 | 73 | 4 | SM00490 | |
| Domain | Helicase_C | 8.47e-04 | 108 | 73 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 8.77e-04 | 109 | 73 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 8.77e-04 | 109 | 73 | 4 | PS51192 | |
| Domain | DEXDc | 8.77e-04 | 109 | 73 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.07e-04 | 110 | 73 | 4 | IPR014001 | |
| Domain | AT_hook | 1.75e-03 | 16 | 73 | 2 | PF02178 | |
| Domain | Zinc_finger_PHD-type_CS | 2.10e-03 | 65 | 73 | 3 | IPR019786 | |
| Domain | PWWP | 2.74e-03 | 20 | 73 | 2 | SM00293 | |
| Domain | PWWP | 3.61e-03 | 23 | 73 | 2 | PF00855 | |
| Domain | PWWP_dom | 3.61e-03 | 23 | 73 | 2 | IPR000313 | |
| Domain | PWWP | 3.93e-03 | 24 | 73 | 2 | PS50812 | |
| Domain | Chromo_domain | 3.93e-03 | 24 | 73 | 2 | IPR023780 | |
| Domain | Chromo | 4.61e-03 | 26 | 73 | 2 | PF00385 | |
| Domain | CHROMO_1 | 5.33e-03 | 28 | 73 | 2 | PS00598 | |
| Domain | CHROMO_2 | 5.33e-03 | 28 | 73 | 2 | PS50013 | |
| Domain | HMGI/Y_DNA-bd_CS | 6.51e-03 | 31 | 73 | 2 | IPR000637 | |
| Domain | Chromodomain-like | 6.93e-03 | 32 | 73 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 7.36e-03 | 33 | 73 | 2 | IPR000953 | |
| Domain | CHROMO | 7.36e-03 | 33 | 73 | 2 | SM00298 | |
| Pubmed | NOLC1 USP8 FRA10AC1 LIMA1 C2CD3 INTS12 PRELID1 PSIP1 FAM133A BCLAF1 SCG3 RBMX2 PCLO KIF21A NCAPD2 NUP98 KMT2A MLLT1 MACF1 BOD1L1 SPAG17 NIPBL TOP1 HNRNPCL3 | 2.62e-15 | 1442 | 76 | 24 | 35575683 | |
| Pubmed | NOLC1 PPIG PSIP1 BCLAF1 DDX18 ZMYND8 NCAPD2 NUP98 NUCKS1 KMT2A TOMM34 DIDO1 PRPF38B CHD8 CHD1 BOD1L1 XPA NIPBL TOP1 | 4.56e-13 | 1014 | 76 | 19 | 32416067 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 PPIG LIMA1 PSIP1 BCLAF1 RBMX2 ZMYND8 NUP98 ZBTB40 NUCKS1 KMT2A DIDO1 PRPF38B NKAP NIPBL GOLGA4 | 9.72e-12 | 774 | 76 | 16 | 15302935 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 PPIG PSIP1 MAP2 BCLAF1 SCG3 RBMX2 DDX18 ZMYND8 NUCKS1 MACF1 DIDO1 PRPF38B ZCCHC17 RSRC2 NKAPL NIPBL TOP1 | 1.48e-11 | 1082 | 76 | 18 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 PSIP1 BCLAF1 DDX18 ZMYND8 NUP98 ANKRD11 KMT2A SLU7 MLLT1 DIDO1 CHD8 CHD1 BOD1L1 NIPBL TOP1 HNRNPCL3 | 2.05e-11 | 954 | 76 | 17 | 36373674 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 USP8 LIMA1 PSIP1 BCLAF1 ZMYND8 NUP98 NUCKS1 KMT2A MACF1 DIDO1 PRPF38B CHD1 BOD1L1 NIPBL TOP1 | 1.55e-10 | 934 | 76 | 16 | 33916271 |
| Pubmed | NOLC1 TCF7L2 INTS12 PSIP1 BCLAF1 ZMYND8 ZBTB40 NUCKS1 KMT2A TOMM34 SLU7 DIDO1 PRPF38B CHD8 RSRC2 NIPBL TOP1 | 1.93e-10 | 1103 | 76 | 17 | 34189442 | |
| Pubmed | 2.01e-10 | 251 | 76 | 10 | 31076518 | ||
| Pubmed | NOLC1 PPIG LIMA1 PSIP1 DDX18 TOMM34 SLU7 BOD1L1 ZCCHC17 RSRC2 SPAG17 TOP1 | 7.51e-10 | 491 | 76 | 12 | 36273042 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 PPIG TCF7L2 INTS12 PSIP1 BCLAF1 RBMX2 DDX18 ZMYND8 NUP98 ANKRD11 KMT2A MLLT1 DIDO1 ZNF740 NIPBL TOP1 | 2.17e-09 | 1294 | 76 | 17 | 30804502 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 DPYD PPIG BCLAF1 MACF1 DIDO1 PRPF38B ZCCHC17 NKAP TOP1 | 6.67e-09 | 361 | 76 | 10 | 26167880 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TCF7L2 INTS12 PSIP1 RBMX2 ZBTB40 KMT2A DIDO1 CHD8 CHD1 BOD1L1 NIPBL TOP1 | 8.20e-09 | 608 | 76 | 12 | 36089195 |
| Pubmed | JARID2 INTS12 RBMX2 ZMYND8 NCAPD2 ANKRD11 LAMA5 KMT2A MLLT1 MACF1 DIDO1 PRPF38B CHD8 CHD1 NKAP RSRC2 NIPBL | 1.87e-08 | 1497 | 76 | 17 | 31527615 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 16096649 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 4.56e-08 | 330 | 76 | 9 | 33301849 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.03e-08 | 341 | 76 | 9 | 32971831 | |
| Pubmed | PSIP1 ZMYND8 NUCKS1 MLLT1 MACF1 DIDO1 PRPF38B CHD8 CHD1 GOLGA4 | 8.27e-08 | 472 | 76 | 10 | 38943005 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 PPIG RBMX2 DDX18 ZMYND8 NUP98 KMT2A DIDO1 PRPF38B CHD8 CHD1 ZCCHC17 NKAP NIPBL TOP1 | 1.43e-07 | 1318 | 76 | 15 | 30463901 |
| Pubmed | NOLC1 DDX18 NCAPD2 NUP98 KMT2A MACF1 DIDO1 CHD8 CHD1 NIPBL TOP1 | 1.78e-07 | 653 | 76 | 11 | 22586326 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 PPIG PSIP1 BCLAF1 DDX18 NUCKS1 MACF1 DIDO1 ZCCHC17 NKAP RSRC2 TOP1 | 1.79e-07 | 807 | 76 | 12 | 22681889 |
| Pubmed | Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation. | 2.00e-07 | 6 | 76 | 3 | 35036869 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.03e-07 | 283 | 76 | 8 | 30585729 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SEPTIN8 LIMA1 PSIP1 BCLAF1 KIF21A NCAPD2 NUCKS1 MACF1 PRPF38B BOD1L1 NIPBL TOP1 | 3.00e-07 | 847 | 76 | 12 | 35235311 |
| Pubmed | NOLC1 LIMA1 TCF7L2 INTS12 DDX18 ZMYND8 NUP98 ZBTB40 KMT2A SLU7 MLLT1 DIDO1 CHD8 NIPBL TOP1 | 4.01e-07 | 1429 | 76 | 15 | 35140242 | |
| Pubmed | 8.75e-07 | 469 | 76 | 9 | 27634302 | ||
| Pubmed | 1.19e-06 | 10 | 76 | 3 | 20153263 | ||
| Pubmed | 1.56e-06 | 503 | 76 | 9 | 16964243 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 2.00e-06 | 41 | 76 | 4 | 20431927 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 2.12e-06 | 269 | 76 | 7 | 29511261 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 JARID2 PSIP1 BCLAF1 PCLO DDX18 NCAPD2 NUP98 NUCKS1 CHD1 BOD1L1 NIPBL TOP1 GOLGA4 | 2.24e-06 | 1425 | 76 | 14 | 30948266 |
| Pubmed | 2.35e-06 | 529 | 76 | 9 | 14621295 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.50e-06 | 533 | 76 | 9 | 30554943 | |
| Pubmed | 2.53e-06 | 396 | 76 | 8 | 26687479 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 USP8 LIMA1 C2CD3 INTS12 MAP2 ANKRD11 KMT2A MACF1 BOD1L1 GOLGA4 | 2.66e-06 | 861 | 76 | 11 | 36931259 |
| Pubmed | 2.83e-06 | 281 | 76 | 7 | 24163370 | ||
| Pubmed | NOLC1 PPIG LIMA1 TCF7L2 BCLAF1 KIF21A DDX18 NUP98 MLLT1 MLLT3 PRPF38B RSRC2 TOP1 | 2.85e-06 | 1247 | 76 | 13 | 27684187 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.32e-06 | 411 | 76 | 8 | 35182466 | |
| Pubmed | 3.59e-06 | 14 | 76 | 3 | 20854876 | ||
| Pubmed | DMTF1 NOLC1 SEPTIN8 OGFRL1 USP45 ZBTB40 SLU7 MACF1 DIDO1 BOD1L1 XPA POLK | 3.91e-06 | 1084 | 76 | 12 | 11544199 | |
| Pubmed | USP8 SCG3 KIF21A DDX18 PDE4DIP ZMYND8 MACF1 MLLT3 SPARCL1 NIPBL TOP1 BRWD3 RYR3 | 3.95e-06 | 1285 | 76 | 13 | 35914814 | |
| Pubmed | 4.03e-06 | 191 | 76 | 6 | 24146773 | ||
| Pubmed | 4.33e-06 | 731 | 76 | 10 | 29298432 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27344946 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20395514 | ||
| Pubmed | t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. | 4.71e-06 | 2 | 76 | 2 | 15725483 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15265687 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36435883 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23318960 | ||
| Pubmed | Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias. | 4.71e-06 | 2 | 76 | 2 | 32768438 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17252016 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34174329 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21953510 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 38576284 | ||
| Pubmed | MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells. | 4.71e-06 | 2 | 76 | 2 | 39002676 | |
| Pubmed | Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia. | 4.71e-06 | 2 | 76 | 2 | 8378076 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21959947 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23178754 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20558618 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19029444 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22103895 | ||
| Pubmed | Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. | 4.71e-06 | 2 | 76 | 2 | 11265751 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10556215 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16916793 | ||
| Pubmed | An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias. | 4.71e-06 | 2 | 76 | 2 | 25509985 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22427200 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30387535 | ||
| Pubmed | NOLC1 ATP7B DDX18 ZMYND8 MLLT1 MACF1 ZNF740 CHD8 NKAP RSRC2 TOP1 BRWD3 | 5.25e-06 | 1116 | 76 | 12 | 31753913 | |
| Pubmed | 6.60e-06 | 55 | 76 | 4 | 27114453 | ||
| Pubmed | 6.67e-06 | 17 | 76 | 3 | 24124579 | ||
| Pubmed | 6.94e-06 | 210 | 76 | 6 | 16565220 | ||
| Pubmed | PPIG PSIP1 FAM133A BCLAF1 RBMX2 DDX18 KMT2A DIDO1 PRPF38B ZCCHC17 NKAP RSRC2 TOP1 | 7.93e-06 | 1371 | 76 | 13 | 36244648 | |
| Pubmed | 7.99e-06 | 18 | 76 | 3 | 21030982 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 8.75e-06 | 59 | 76 | 4 | 16083285 | |
| Pubmed | 9.52e-06 | 222 | 76 | 6 | 37071664 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.19e-05 | 231 | 76 | 6 | 16452087 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.32e-05 | 497 | 76 | 8 | 36774506 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.34e-05 | 498 | 76 | 8 | 36634849 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18829457 | ||
| Pubmed | Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide. | 1.41e-05 | 3 | 76 | 2 | 18829459 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28392395 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25305204 | ||
| Pubmed | NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. | 1.41e-05 | 3 | 76 | 2 | 27889185 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19880519 | ||
| Pubmed | Menin critically links MLL proteins with LEDGF on cancer-associated target genes. | 1.41e-05 | 3 | 76 | 2 | 18598942 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28210005 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 16328057 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33477970 | ||
| Pubmed | Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. | 1.41e-05 | 3 | 76 | 2 | 11829491 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23624644 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22046413 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12781363 | ||
| Pubmed | The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3. | 1.41e-05 | 3 | 76 | 2 | 11313972 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10995463 | ||
| Pubmed | NKAP is a transcriptional repressor of notch signaling and is required for T cell development. | 1.41e-05 | 3 | 76 | 2 | 19409814 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 16433901 | ||
| Pubmed | MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1. | 1.41e-05 | 3 | 76 | 2 | 37852994 | |
| Pubmed | The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. | 1.41e-05 | 3 | 76 | 2 | 34582559 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 32549410 | ||
| Pubmed | FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis. | 1.41e-05 | 3 | 76 | 2 | 30953031 | |
| Pubmed | Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. | 1.41e-05 | 3 | 76 | 2 | 18538732 | |
| Interaction | JMJD6 interactions | PPIG FAM133A RBMX2 SLU7 DIDO1 PRPF38B ZCCHC17 NKAP RSRC2 TOP1 | 4.44e-09 | 205 | 75 | 10 | int:JMJD6 |
| Interaction | CIT interactions | NOLC1 LIMA1 PSIP1 BCLAF1 PCLO DDX18 ZMYND8 NUP98 KMT2A MACF1 DIDO1 HNRNPCL4 PRPF38B CHD8 CHD1 BOD1L1 SPAG17 NKAPL NIPBL TOP1 GOLGA4 HNRNPCL3 | 7.77e-09 | 1450 | 75 | 22 | int:CIT |
| Interaction | NUP43 interactions | PSIP1 BCLAF1 RBMX2 DDX18 ZMYND8 NUP98 ANKRD11 KMT2A CHD8 CHD1 BOD1L1 XPA NKAP NIPBL TOP1 | 8.14e-09 | 625 | 75 | 15 | int:NUP43 |
| Interaction | CSNK2A1 interactions | NOLC1 TCF7L2 INTS12 PSIP1 FAM133A BCLAF1 ZMYND8 NCAPD2 NUP98 ANKRD11 NUCKS1 KMT2A MLLT1 MACF1 ZCCHC17 NKAP TOP1 BRWD3 | 9.32e-09 | 956 | 75 | 18 | int:CSNK2A1 |
| Interaction | CEBPA interactions | NOLC1 TCF7L2 INTS12 PSIP1 BCLAF1 DDX18 ZMYND8 ZBTB40 NUCKS1 KMT2A TOMM34 SLU7 MACF1 DIDO1 PRPF38B CHD8 CHD1 RSRC2 NIPBL TOP1 | 1.73e-08 | 1245 | 75 | 20 | int:CEBPA |
| Interaction | POLR1G interactions | NOLC1 RBMX2 DDX18 ZMYND8 ANKRD11 KMT2A SLU7 MLLT1 CHD8 CHD1 RSRC2 NIPBL TOP1 | 2.77e-08 | 489 | 75 | 13 | int:POLR1G |
| Interaction | BRD3 interactions | NOLC1 INTS12 PSIP1 DDX18 ZMYND8 KMT2A ZNF740 CHD8 CHD1 NKAP RSRC2 NIPBL TOP1 | 3.12e-08 | 494 | 75 | 13 | int:BRD3 |
| Interaction | TERF2IP interactions | PSIP1 ZMYND8 ANKRD11 NUCKS1 KMT2A SLU7 DIDO1 CHD8 CHD1 BOD1L1 RSRC2 NIPBL TOP1 | 1.14e-07 | 552 | 75 | 13 | int:TERF2IP |
| Interaction | SMC5 interactions | NOLC1 PSIP1 BCLAF1 DDX18 ZMYND8 NUP98 ANKRD11 KMT2A SLU7 MLLT1 DIDO1 CHD8 CHD1 BOD1L1 NIPBL TOP1 HNRNPCL3 | 1.14e-07 | 1000 | 75 | 17 | int:SMC5 |
| Interaction | UBE2O interactions | NOLC1 PPIG LIMA1 PSIP1 DDX18 TOMM34 SLU7 MLLT1 MACF1 BOD1L1 ZCCHC17 NKAP RSRC2 SPAG17 TOP1 | 1.77e-07 | 790 | 75 | 15 | int:UBE2O |
| Interaction | DDX23 interactions | NOLC1 PPIG BCLAF1 RBMX2 DDX18 ANKRD11 SLU7 MLLT1 CHD1 NKAP RSRC2 TOP1 | 1.95e-07 | 480 | 75 | 12 | int:DDX23 |
| Interaction | H2BC21 interactions | USP8 C2CD3 PSIP1 BCLAF1 PCLO ZMYND8 NUCKS1 KMT2A SLU7 MLLT1 DIDO1 CHD8 NIPBL TOP1 | 2.41e-07 | 696 | 75 | 14 | int:H2BC21 |
| Interaction | CSNK2B interactions | NOLC1 USP45 TCF7L2 FAM133A BCLAF1 RBMX2 ZMYND8 ANKRD11 KMT2A DIDO1 CHD8 ZCCHC17 NKAP | 4.69e-07 | 625 | 75 | 13 | int:CSNK2B |
| Interaction | NAA40 interactions | NOLC1 USP8 LIMA1 PSIP1 BCLAF1 ZMYND8 NUP98 NUCKS1 KMT2A MACF1 DIDO1 PRPF38B CHD1 BOD1L1 NIPBL TOP1 | 4.82e-07 | 978 | 75 | 16 | int:NAA40 |
| Interaction | H3-3A interactions | TCF7L2 INTS12 PSIP1 ZBTB40 KMT2A DIDO1 MLLT3 CHD8 CHD1 BOD1L1 POLK NIPBL TOP1 BRWD3 | 5.82e-07 | 749 | 75 | 14 | int:H3-3A |
| Interaction | NKAP interactions | 6.04e-07 | 132 | 75 | 7 | int:NKAP | |
| Interaction | ZNF330 interactions | NOLC1 PSIP1 DDX18 ZMYND8 ANKRD11 KMT2A SLU7 MLLT1 CHD1 NIPBL TOP1 | 7.56e-07 | 446 | 75 | 11 | int:ZNF330 |
| Interaction | UHRF2 interactions | 7.81e-07 | 200 | 75 | 8 | int:UHRF2 | |
| Interaction | MECP2 interactions | NOLC1 PPIG PSIP1 MAP2 BCLAF1 SCG3 RBMX2 DDX18 ZMYND8 NUCKS1 MACF1 DIDO1 PRPF38B ZCCHC17 RSRC2 NKAPL NIPBL TOP1 | 8.11e-07 | 1287 | 75 | 18 | int:MECP2 |
| Interaction | MEN1 interactions | NOLC1 TCF7L2 PSIP1 BCLAF1 DDX18 SETBP1 ZMYND8 NCAPD2 NUP98 LAMA5 KMT2A DIDO1 CHD8 CHD1 BOD1L1 TOP1 | 9.45e-07 | 1029 | 75 | 16 | int:MEN1 |
| Interaction | BPIFB1 interactions | 1.56e-06 | 53 | 75 | 5 | int:BPIFB1 | |
| Interaction | KMT2A interactions | 2.46e-06 | 314 | 75 | 9 | int:KMT2A | |
| Interaction | OBSL1 interactions | NOLC1 LIMA1 PSIP1 MAP2 BCLAF1 PCLO DDX18 NUP98 LAMA5 MACF1 PRPF38B CHD1 NIPBL TOP1 | 5.14e-06 | 902 | 75 | 14 | int:OBSL1 |
| Interaction | KIF20A interactions | NOLC1 LIMA1 PSIP1 BCLAF1 PCLO DDX18 NUP98 NUCKS1 MACF1 DIDO1 CHD8 CHD1 BOD1L1 TOP1 HNRNPCL3 | 6.30e-06 | 1052 | 75 | 15 | int:KIF20A |
| Interaction | ZBTB2 interactions | NOLC1 PPIG BCLAF1 RBMX2 KIF21A DDX18 ZMYND8 TOMM34 CHD1 TOP1 | 6.32e-06 | 450 | 75 | 10 | int:ZBTB2 |
| Interaction | RAD18 interactions | 7.23e-06 | 457 | 75 | 10 | int:RAD18 | |
| Interaction | H2BC8 interactions | PSIP1 ZMYND8 NUCKS1 KMT2A SLU7 DIDO1 CHD8 CHD1 RSRC2 NIPBL TOP1 | 8.83e-06 | 576 | 75 | 11 | int:H2BC8 |
| Interaction | RBBP5 interactions | 1.13e-05 | 287 | 75 | 8 | int:RBBP5 | |
| Interaction | SRPK2 interactions | NOLC1 PPIG BCLAF1 RBMX2 DDX18 MACF1 DIDO1 PRPF38B ZCCHC17 NKAP RSRC2 TOP1 | 1.26e-05 | 717 | 75 | 12 | int:SRPK2 |
| Interaction | CSNK2A2 interactions | NOLC1 TCF7L2 FAM133A BCLAF1 ZMYND8 NUCKS1 KMT2A ZCCHC17 NKAP NKAPL TOP1 BRWD3 | 1.27e-05 | 718 | 75 | 12 | int:CSNK2A2 |
| Interaction | PSENEN interactions | 1.28e-05 | 81 | 75 | 5 | int:PSENEN | |
| Interaction | DHX8 interactions | 1.28e-05 | 292 | 75 | 8 | int:DHX8 | |
| Interaction | MACROH2A2 interactions | 1.36e-05 | 211 | 75 | 7 | int:MACROH2A2 | |
| Interaction | SOX2 interactions | SEPTIN8 LIMA1 C2CD3 TCF7L2 PSIP1 BCLAF1 DDX18 ZMYND8 NCAPD2 NUP98 KMT2A MLLT1 MACF1 CHD8 BOD1L1 NIPBL TOP1 | 1.42e-05 | 1422 | 75 | 17 | int:SOX2 |
| Interaction | PAF1 interactions | 1.49e-05 | 214 | 75 | 7 | int:PAF1 | |
| Interaction | PIP4K2A interactions | 1.58e-05 | 216 | 75 | 7 | int:PIP4K2A | |
| Interaction | PEA15 interactions | 2.14e-05 | 90 | 75 | 5 | int:PEA15 | |
| Interaction | MDK interactions | 2.26e-05 | 91 | 75 | 5 | int:MDK | |
| Interaction | BRD2 interactions | 2.99e-05 | 429 | 75 | 9 | int:BRD2 | |
| Interaction | COIL interactions | 3.67e-05 | 552 | 75 | 10 | int:COIL | |
| Interaction | SSRP1 interactions | NOLC1 INTS12 BCLAF1 ZMYND8 ANKRD11 KMT2A DIDO1 CHD1 NIPBL TOP1 BRWD3 | 4.37e-05 | 685 | 75 | 11 | int:SSRP1 |
| Interaction | IFI6 interactions | 4.86e-05 | 54 | 75 | 4 | int:IFI6 | |
| Interaction | ASH2L interactions | 5.82e-05 | 265 | 75 | 7 | int:ASH2L | |
| Interaction | HECTD1 interactions | NOLC1 PSIP1 FAM133A DDX18 NCAPD2 ANKRD11 SLU7 MACF1 DIDO1 PRPF38B ZCCHC17 NKAP TOP1 | 6.27e-05 | 984 | 75 | 13 | int:HECTD1 |
| Interaction | AFF4 interactions | 6.96e-05 | 115 | 75 | 5 | int:AFF4 | |
| Interaction | CHMP4B interactions | NOLC1 USP8 LIMA1 BCLAF1 RBMX2 EFCAB13 NUP98 CIR1 CHD1 ZCCHC17 TOP1 | 7.46e-05 | 727 | 75 | 11 | int:CHMP4B |
| Interaction | CENPA interactions | 7.88e-05 | 377 | 75 | 8 | int:CENPA | |
| Interaction | H3C3 interactions | 9.02e-05 | 495 | 75 | 9 | int:H3C3 | |
| Interaction | SIRT7 interactions | NOLC1 DDX18 NCAPD2 NUP98 KMT2A MACF1 DIDO1 CHD8 CHD1 NIPBL TOP1 | 9.17e-05 | 744 | 75 | 11 | int:SIRT7 |
| Interaction | H3C1 interactions | PSIP1 DDX18 ZMYND8 NUCKS1 KMT2A MLLT1 DIDO1 MLLT3 CHD8 CHD1 NIPBL TOP1 | 1.15e-04 | 901 | 75 | 12 | int:H3C1 |
| Interaction | EAF1 interactions | 1.16e-04 | 128 | 75 | 5 | int:EAF1 | |
| Interaction | FHL1 interactions | 1.20e-04 | 129 | 75 | 5 | int:FHL1 | |
| Interaction | PNN interactions | 1.31e-04 | 302 | 75 | 7 | int:PNN | |
| Interaction | SUZ12 interactions | NOLC1 JARID2 LIMA1 BCLAF1 DDX18 NCAPD2 NUCKS1 CHD8 CHD1 TOP1 | 1.32e-04 | 644 | 75 | 10 | int:SUZ12 |
| Interaction | CBX3 interactions | 1.35e-04 | 646 | 75 | 10 | int:CBX3 | |
| Interaction | MYCN interactions | NOLC1 PPIG LIMA1 PSIP1 MAP2 BCLAF1 RBMX2 DDX18 ZMYND8 KMT2A DIDO1 PRPF38B ZCCHC17 NKAP TOP1 | 1.38e-04 | 1373 | 75 | 15 | int:MYCN |
| Interaction | LLGL2 interactions | 1.38e-04 | 133 | 75 | 5 | int:LLGL2 | |
| Interaction | GATA4 interactions | 1.43e-04 | 411 | 75 | 8 | int:GATA4 | |
| Interaction | XRCC6 interactions | TCF7L2 INTS12 PSIP1 BCLAF1 ZMYND8 NCAPD2 KMT2A SLU7 DIDO1 CHD8 BOD1L1 TOP1 | 1.52e-04 | 928 | 75 | 12 | int:XRCC6 |
| Interaction | NR2C2 interactions | NOLC1 PPIG RBMX2 DDX18 ZMYND8 NUP98 KMT2A DIDO1 PRPF38B CHD8 CHD1 ZCCHC17 NKAP NIPBL TOP1 | 1.75e-04 | 1403 | 75 | 15 | int:NR2C2 |
| Interaction | SETBP1 interactions | 1.87e-04 | 30 | 75 | 3 | int:SETBP1 | |
| Interaction | HECW2 interactions | 1.95e-04 | 322 | 75 | 7 | int:HECW2 | |
| Interaction | DSCR9 interactions | 2.21e-04 | 147 | 75 | 5 | int:DSCR9 | |
| Interaction | CHMP4C interactions | 2.23e-04 | 687 | 75 | 10 | int:CHMP4C | |
| Interaction | ELL interactions | 2.26e-04 | 80 | 75 | 4 | int:ELL | |
| Interaction | PLCD4 interactions | 2.27e-04 | 32 | 75 | 3 | int:PLCD4 | |
| Interaction | INTS3 interactions | 2.28e-04 | 148 | 75 | 5 | int:INTS3 | |
| Interaction | THRAP3 interactions | 2.38e-04 | 443 | 75 | 8 | int:THRAP3 | |
| Interaction | ZCCHC10 interactions | 2.48e-04 | 236 | 75 | 6 | int:ZCCHC10 | |
| Interaction | PRPF40A interactions | 2.49e-04 | 446 | 75 | 8 | int:PRPF40A | |
| Interaction | SLX4 interactions | 2.66e-04 | 572 | 75 | 9 | int:SLX4 | |
| Interaction | DYNLT1 interactions | 2.78e-04 | 241 | 75 | 6 | int:DYNLT1 | |
| Interaction | MLLT3 interactions | 2.85e-04 | 85 | 75 | 4 | int:MLLT3 | |
| Interaction | DENND2D interactions | 3.24e-04 | 36 | 75 | 3 | int:DENND2D | |
| Interaction | NKAPD1 interactions | 3.36e-04 | 161 | 75 | 5 | int:NKAPD1 | |
| Interaction | HNRNPCL1 interactions | 3.36e-04 | 161 | 75 | 5 | int:HNRNPCL1 | |
| Interaction | RNF2 interactions | NOLC1 LIMA1 BCLAF1 PCLO DDX18 PDE4DIP KMT2A MLLT1 MLLT3 ZNF740 TOP1 | 3.43e-04 | 866 | 75 | 11 | int:RNF2 |
| Interaction | RBPJ interactions | 3.68e-04 | 254 | 75 | 6 | int:RBPJ | |
| Interaction | HCFC2 interactions | 3.86e-04 | 92 | 75 | 4 | int:HCFC2 | |
| Interaction | KIF23 interactions | NOLC1 USP8 PPIG LIMA1 C2CD3 BCLAF1 PCLO DDX18 MACF1 PRPF38B CHD1 TOP1 | 3.99e-04 | 1031 | 75 | 12 | int:KIF23 |
| Interaction | H2BC4 interactions | 4.08e-04 | 259 | 75 | 6 | int:H2BC4 | |
| Interaction | PPIA interactions | PSIP1 PTPRG ZMYND8 NUCKS1 MLLT1 MACF1 DIDO1 PRPF38B CHD8 CHD1 GOLGA4 | 4.24e-04 | 888 | 75 | 11 | int:PPIA |
| Interaction | LINC02910 interactions | 4.36e-04 | 95 | 75 | 4 | int:LINC02910 | |
| Interaction | PIM2 interactions | 4.43e-04 | 40 | 75 | 3 | int:PIM2 | |
| Interaction | NPM1 interactions | PSIP1 BCLAF1 RBMX2 DDX18 PDE4DIP ZMYND8 NUP98 KMT2A LMOD1 DIDO1 CHD8 CHD1 TOP1 | 4.48e-04 | 1201 | 75 | 13 | int:NPM1 |
| Interaction | EPB41L3 interactions | 5.28e-04 | 272 | 75 | 6 | int:EPB41L3 | |
| Interaction | NBR1 interactions | 5.29e-04 | 380 | 75 | 7 | int:NBR1 | |
| Interaction | MAPRE1 interactions | 6.39e-04 | 514 | 75 | 8 | int:MAPRE1 | |
| Interaction | YWHAG interactions | NOLC1 USP8 PPIG LIMA1 C2CD3 MAP2 BCLAF1 ANKRD11 KMT2A MACF1 PRPF38B BOD1L1 NKAP | 6.43e-04 | 1248 | 75 | 13 | int:YWHAG |
| Interaction | CHD4 interactions | NOLC1 TCF7L2 PSIP1 BCLAF1 DDX18 ZMYND8 NCAPD2 KMT2A SLU7 MLLT3 TOP1 | 6.70e-04 | 938 | 75 | 11 | int:CHD4 |
| Interaction | ANKRD50 interactions | 7.08e-04 | 108 | 75 | 4 | int:ANKRD50 | |
| Interaction | WDR5 interactions | PSIP1 BCLAF1 DDX18 SETBP1 NUP98 NUCKS1 KMT2A TOMM34 MLLT1 MACF1 CHD8 BOD1L1 | 7.16e-04 | 1101 | 75 | 12 | int:WDR5 |
| Interaction | H1-4 interactions | 7.18e-04 | 656 | 75 | 9 | int:H1-4 | |
| Interaction | CSNK2A3 interactions | 7.58e-04 | 110 | 75 | 4 | int:CSNK2A3 | |
| Interaction | HCFC1 interactions | 7.80e-04 | 293 | 75 | 6 | int:HCFC1 | |
| Interaction | DOT1L interactions | 7.88e-04 | 807 | 75 | 10 | int:DOT1L | |
| Interaction | EED interactions | NOLC1 JARID2 LIMA1 BCLAF1 DDX18 NCAPD2 NUP98 NUCKS1 LAMA5 MACF1 DIDO1 ZCCHC17 NIPBL TOP1 | 7.97e-04 | 1445 | 75 | 14 | int:EED |
| Interaction | SUPT5H interactions | 8.05e-04 | 408 | 75 | 7 | int:SUPT5H | |
| Interaction | NOS1AP interactions | 8.38e-04 | 113 | 75 | 4 | int:NOS1AP | |
| Interaction | DUS4L interactions | 8.80e-04 | 12 | 75 | 2 | int:DUS4L | |
| GeneFamily | Super elongation complex|YEATS domain containing | 3.31e-05 | 4 | 43 | 2 | 1283 | |
| GeneFamily | PHD finger proteins | 6.11e-05 | 90 | 43 | 4 | 88 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.97e-04 | 9 | 43 | 2 | 1280 | |
| GeneFamily | PWWP domain containing | 1.24e-03 | 22 | 43 | 2 | 1147 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.31e-03 | 36 | 43 | 2 | 823 | |
| GeneFamily | Ubiquitin specific peptidases | 7.84e-03 | 56 | 43 | 2 | 366 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | USP8 FRA10AC1 PPIG LIMA1 BCLAF1 SLU7 PRPF38B CHD1 NKAP RSRC2 POLK NIPBL GOLGA4 | 4.09e-08 | 656 | 75 | 13 | M18979 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | NOLC1 OGFRL1 PPIG TCF7L2 PTPRG BCLAF1 DDX18 NUCKS1 MLLT1 PRPF38B RSRC2 | 2.58e-07 | 519 | 75 | 11 | M3395 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | NOLC1 OGFRL1 PPIG TCF7L2 PTPRG BCLAF1 DDX18 NUCKS1 MLLT1 PRPF38B RSRC2 | 4.03e-07 | 543 | 75 | 11 | MM997 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.98e-07 | 166 | 75 | 7 | M6826 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 4.02e-06 | 323 | 75 | 8 | M9150 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 9.89e-06 | 484 | 75 | 9 | MM999 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 1.51e-05 | 646 | 75 | 10 | M2419 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DMTF1 JARID2 PPIG PSIP1 BCLAF1 PDE4DIP NUP98 ANKRD11 KMT2A MACF1 PRPF38B CHD1 BOD1L1 RSRC2 NIPBL | 1.79e-05 | 1492 | 75 | 15 | M40023 |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 1.95e-05 | 193 | 75 | 6 | M6730 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 2.01e-05 | 115 | 75 | 5 | M7484 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.20e-05 | 295 | 75 | 7 | M39121 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 2.20e-05 | 675 | 75 | 10 | MM1073 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_DN | 2.25e-05 | 198 | 75 | 6 | M6736 | |
| Coexpression | BENPORATH_NANOG_TARGETS | NOLC1 JARID2 TCF7L2 INTS12 BCLAF1 DDX18 NCAPD2 NUCKS1 DIDO1 RSRC2 GOLGA4 RYR3 | 2.25e-05 | 988 | 75 | 12 | M6616 |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 2.38e-05 | 200 | 75 | 6 | M7031 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 2.60e-05 | 418 | 75 | 8 | MM3752 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | JARID2 DPYD C2CD3 TCF7L2 ZMYND8 NUP98 MACF1 CHD1 NIPBL TOP1 GOLGA4 | 3.08e-05 | 856 | 75 | 11 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 4.95e-05 | 458 | 75 | 8 | M40010 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 5.12e-05 | 337 | 75 | 7 | M13206 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.59e-05 | 466 | 75 | 8 | M13522 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.68e-05 | 467 | 75 | 8 | M1347 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 JARID2 FRA10AC1 USP45 PTPRG CYP3A43 RBMX2 DDX18 NUCKS1 MLLT3 CHD1 | 6.02e-05 | 922 | 75 | 11 | MM1068 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | FRA10AC1 PSIP1 MAP2 SCG3 PCLO KIF21A SETBP1 PDE4DIP NUCKS1 TOMM34 GOLGA4 | 7.57e-05 | 946 | 75 | 11 | M39169 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 8.16e-05 | 363 | 75 | 7 | M41103 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | OGFRL1 PPIG PRELID1 FAM133A ANKRD11 NUCKS1 PRPF38B ZCCHC17 RSRC2 NIPBL TOP1 HNRNPCL3 | 9.27e-05 | 1144 | 75 | 12 | MM3843 |
| Coexpression | BENPORATH_CYCLING_GENES | 9.58e-05 | 648 | 75 | 9 | M8156 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.16e-04 | 166 | 75 | 5 | M8129 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 1.19e-04 | 167 | 75 | 5 | M365 | |
| Coexpression | FAN_EMBRYONIC_CTX_IN_3_INTERNEURON | 1.20e-04 | 6 | 75 | 2 | M39029 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.36e-04 | 394 | 75 | 7 | MM3724 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.44e-04 | 534 | 75 | 8 | MM1054 | |
| Coexpression | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN | 1.77e-04 | 38 | 75 | 3 | M11778 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 1.92e-04 | 185 | 75 | 5 | M19511 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.22e-04 | 300 | 75 | 6 | M8702 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 2.38e-04 | 304 | 75 | 6 | M39113 | |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 2.39e-04 | 194 | 75 | 5 | M8017 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP | 2.39e-04 | 194 | 75 | 5 | M7554 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NOLC1 JARID2 FRA10AC1 USP45 PTPRG RBMX2 DDX18 NUCKS1 MLLT3 CHD1 | 2.47e-04 | 904 | 75 | 10 | M2325 |
| Coexpression | GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN | 2.51e-04 | 196 | 75 | 5 | M5405 | |
| Coexpression | GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN | 2.63e-04 | 198 | 75 | 5 | M5507 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 2.69e-04 | 199 | 75 | 5 | M7596 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.75e-04 | 200 | 75 | 5 | M5851 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP | 2.75e-04 | 200 | 75 | 5 | M4031 | |
| Coexpression | GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 2.75e-04 | 200 | 75 | 5 | M8200 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN | 2.75e-04 | 200 | 75 | 5 | M9827 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_UP | 2.85e-04 | 445 | 75 | 7 | M7928 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP2 PCLO KIF21A PDE4DIP ZMYND8 LAMA5 MLLT3 BOD1L1 XPA SPAG17 HNRNPCL3 | 2.96e-04 | 1106 | 75 | 11 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 4.35e-04 | 221 | 75 | 5 | M39222 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 4.54e-04 | 481 | 75 | 7 | M3898 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SEPTIN8 OGFRL1 PPIG USP45 TCF7L2 INTS12 KIF21A ERCC6L2 MACF1 MLLT3 PRPF38B XPA NKAP POLK NIPBL TOP1 | 8.66e-09 | 780 | 74 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SEPTIN8 OGFRL1 PPIG TCF7L2 SCG3 PCLO KIF21A SETBP1 ERCC6L2 MLLT3 CHD1 BOD1L1 NKAP NIPBL TOP1 GOLGA4 | 2.11e-08 | 831 | 74 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 JARID2 OGFRL1 PPIG INTS12 PSIP1 BCLAF1 RBMX2 KIF21A SETBP1 ANKDD1B MACF1 PRPF38B CHD1 BOD1L1 ZCCHC17 RSRC2 NIPBL TOP1 | 3.90e-08 | 1257 | 74 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 JARID2 OGFRL1 PPIG INTS12 PSIP1 MAP2 BCLAF1 RBMX2 KIF21A SETBP1 ANKDD1B MACF1 PRPF38B CHD1 BOD1L1 ZCCHC17 RSRC2 NIPBL TOP1 | 7.89e-08 | 1459 | 74 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | OGFRL1 PPIG TCF7L2 SETBP1 MLLT3 PRPF38B BOD1L1 NIPBL TOP1 GOLGA4 | 1.23e-07 | 311 | 74 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | JARID2 OGFRL1 PPIG TCF7L2 INTS12 PSIP1 MAP2 BCLAF1 RBMX2 KIF21A SETBP1 ANKDD1B MLLT3 PRPF38B CHD1 BOD1L1 NIPBL TOP1 BRWD3 | 1.51e-07 | 1370 | 74 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NOLC1 JARID2 OGFRL1 FRA10AC1 PPIG LIMA1 INTS12 PSIP1 BCLAF1 MACF1 PRPF38B BOD1L1 ZCCHC17 XPA RSRC2 NIPBL TOP1 BRWD3 | 1.78e-07 | 1241 | 74 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 OGFRL1 PPIG TCF7L2 MAP2 SCG3 PCLO KIF21A SETBP1 MLLT3 PRPF38B CHD1 BOD1L1 NIPBL TOP1 GOLGA4 | 2.29e-07 | 989 | 74 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | PSIP1 BCLAF1 SCG3 PCLO KIF21A ANKRD11 MLLT3 CHD1 ZCCHC17 RSRC2 NIPBL TOP1 | 2.89e-07 | 532 | 74 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | OGFRL1 FRA10AC1 DPYD BCLAF1 SCG3 PCLO KIF21A SETBP1 MLLT3 PRPF38B CHD8 CHD1 RSRC2 | 3.71e-07 | 654 | 74 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | DMTF1 PPIG SCG3 PCLO KIF21A CIR1 SLU7 MACF1 DIDO1 PRPF38B BOD1L1 GOLGA4 | 9.44e-07 | 595 | 74 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | OGFRL1 DPYD PSIP1 MAP2 BCLAF1 SCG3 PCLO KIF21A SETBP1 ANKRD11 PRPF38B CHD8 CHD1 RSRC2 TOP1 | 1.21e-06 | 983 | 74 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.05e-06 | 328 | 74 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 JARID2 OGFRL1 FRA10AC1 PPIG LIMA1 INTS12 PSIP1 BCLAF1 MACF1 PRPF38B BOD1L1 ZCCHC17 XPA RSRC2 NIPBL TOP1 BRWD3 | 2.06e-06 | 1468 | 74 | 18 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.78e-06 | 192 | 74 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | JARID2 OGFRL1 PPIG LIMA1 INTS12 PSIP1 MAP2 BCLAF1 KIF21A MLLT3 PRPF38B CHD1 BOD1L1 NIPBL TOP1 BRWD3 | 5.07e-06 | 1252 | 74 | 16 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | JARID2 TCF7L2 MAP2 BCLAF1 SCG3 PCLO KIF21A SETBP1 MACF1 PRPF38B CHD8 CHD1 NIPBL TOP1 | 6.67e-06 | 986 | 74 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.25e-06 | 298 | 74 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PPIG KIF21A CIR1 SLU7 MACF1 DIDO1 PRPF38B BOD1L1 NIPBL TOP1 BRWD3 | 1.09e-05 | 629 | 74 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.89e-05 | 432 | 74 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 2.37e-05 | 98 | 74 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 JARID2 PRELID1 SCG3 RBMX2 PCLO KIF21A DDX18 LAMA5 MLLT3 CHD1 ZCCHC17 TOP1 | 3.42e-05 | 991 | 74 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | NOLC1 JARID2 PPIG INTS12 PRELID1 PSIP1 BCLAF1 RBMX2 DDX18 MLLT3 PRPF38B CHD1 ZCCHC17 TOP1 | 4.25e-05 | 1164 | 74 | 14 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.71e-05 | 186 | 74 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NOLC1 JARID2 PPIG INTS12 PRELID1 PSIP1 BCLAF1 RBMX2 DDX18 LAMA5 MLLT3 PRPF38B CHD1 ZCCHC17 TOP1 | 5.26e-05 | 1347 | 74 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 5.28e-05 | 493 | 74 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 5.53e-05 | 496 | 74 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.09e-05 | 285 | 74 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NOLC1 JARID2 PPIG TCF7L2 PRELID1 PSIP1 BCLAF1 RBMX2 KIF21A DDX18 PRPF38B CHD1 XPA TOP1 BRWD3 | 6.43e-05 | 1371 | 74 | 15 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.94e-05 | 291 | 74 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 7.31e-05 | 124 | 74 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.86e-05 | 204 | 74 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.05e-05 | 298 | 74 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | FRA10AC1 C2CD3 MAP2 SCG3 PCLO KIF21A SETBP1 MACF1 MLLT3 CHD8 | 9.29e-05 | 659 | 74 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.25e-04 | 139 | 74 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PPIG LIMA1 MAP2 PCLO KIF21A CIR1 MACF1 PRPF38B BOD1L1 NIPBL TOP1 BRWD3 | 1.48e-04 | 989 | 74 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | NOLC1 JARID2 TCF7L2 MAP2 PCLO KIF21A ZMYND8 ANKRD11 LAMA5 HES1 RSRC2 NIPBL | 1.56e-04 | 994 | 74 | 12 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.59e-04 | 232 | 74 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.24e-04 | 469 | 74 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | FRA10AC1 C2CD3 TCF7L2 MAP2 BCLAF1 SCG3 PCLO KIF21A SETBP1 MLLT3 CHD8 | 2.53e-04 | 893 | 74 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 2.70e-04 | 256 | 74 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | PPIG INTS12 PSIP1 BCLAF1 KIF21A SETBP1 MACF1 PRPF38B CHD1 BOD1L1 NIPBL TOP1 | 2.82e-04 | 1060 | 74 | 12 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.88e-04 | 259 | 74 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 3.10e-04 | 492 | 74 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 3.36e-04 | 498 | 74 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | OGFRL1 PPIG LIMA1 TCF7L2 PCLO KIF21A MACF1 PRPF38B XPA NIPBL TOP1 | 5.81e-04 | 985 | 74 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | USP45 PSIP1 MAP2 KIF21A PDE4DIP ERCC6L2 MLLT3 CHD1 TERB2 BRWD3 | 6.22e-04 | 836 | 74 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.02e-04 | 202 | 74 | 5 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.62e-04 | 564 | 74 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.08e-03 | 129 | 74 | 4 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | PPIG INTS12 PSIP1 MAP2 BCLAF1 KIF21A SETBP1 MACF1 PRPF38B CHD1 BOD1L1 NIPBL TOP1 | 1.11e-03 | 1414 | 74 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | BCLAF1 ANKRD11 KMT2A MACF1 CHD1 BOD1L1 RSRC2 NIPBL TOP1 GOLGA4 | 1.78e-12 | 200 | 76 | 10 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.70e-11 | 198 | 76 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.96e-11 | 199 | 76 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.23e-11 | 200 | 76 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-10 | 184 | 76 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-09 | 188 | 76 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-09 | 195 | 76 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-09 | 195 | 76 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-08 | 187 | 76 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-08 | 194 | 76 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.70e-08 | 197 | 76 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.70e-08 | 197 | 76 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.86e-08 | 198 | 76 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-08 | 198 | 76 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.03e-08 | 199 | 76 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.03e-08 | 199 | 76 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.03e-08 | 199 | 76 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.43e-07 | 188 | 76 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.24e-07 | 191 | 76 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.17e-06 | 199 | 76 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.17e-06 | 199 | 76 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.17e-06 | 199 | 76 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.21e-06 | 200 | 76 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.91e-06 | 138 | 76 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 189 | 76 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 192 | 76 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-05 | 193 | 76 | 5 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.99e-05 | 193 | 76 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-05 | 194 | 76 | 5 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-05 | 194 | 76 | 5 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-05 | 197 | 76 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | myeloid-Monocyte-CD16+_Monocyte|myeloid / Lineage, cell class and subclass | 2.20e-05 | 197 | 76 | 5 | 7ed5dc82ead20406586252ef07164afad8a49994 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 2.25e-05 | 198 | 76 | 5 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.25e-05 | 198 | 76 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.30e-05 | 199 | 76 | 5 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 2.30e-05 | 199 | 76 | 5 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.30e-05 | 199 | 76 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.30e-05 | 199 | 76 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.36e-05 | 200 | 76 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.36e-05 | 200 | 76 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-05 | 200 | 76 | 5 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.30e-04 | 151 | 76 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.54e-04 | 158 | 76 | 4 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 169 | 76 | 4 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.04e-04 | 170 | 76 | 4 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.04e-04 | 170 | 76 | 4 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.04e-04 | 170 | 76 | 4 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.04e-04 | 170 | 76 | 4 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-04 | 174 | 76 | 4 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 2.28e-04 | 175 | 76 | 4 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 175 | 76 | 4 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-04 | 175 | 76 | 4 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 175 | 76 | 4 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 2.38e-04 | 177 | 76 | 4 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.38e-04 | 177 | 76 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.43e-04 | 178 | 76 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.49e-04 | 179 | 76 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 2.59e-04 | 181 | 76 | 4 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 182 | 76 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-04 | 183 | 76 | 4 | 8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 184 | 76 | 4 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 76 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 2.88e-04 | 186 | 76 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.88e-04 | 186 | 76 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.94e-04 | 187 | 76 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.94e-04 | 187 | 76 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.94e-04 | 187 | 76 | 4 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 188 | 76 | 4 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.00e-04 | 188 | 76 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 188 | 76 | 4 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 188 | 76 | 4 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.06e-04 | 189 | 76 | 4 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.06e-04 | 189 | 76 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.06e-04 | 189 | 76 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 190 | 76 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 190 | 76 | 4 | a28e14fff75c36b1a8634eaf3f305e3206fdc2ed | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.12e-04 | 190 | 76 | 4 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 3.12e-04 | 190 | 76 | 4 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.12e-04 | 190 | 76 | 4 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 3.18e-04 | 191 | 76 | 4 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.18e-04 | 191 | 76 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-04 | 191 | 76 | 4 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | control-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.18e-04 | 191 | 76 | 4 | 7122957972f177a1d846d965cef53cfe7568ba54 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 191 | 76 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-04 | 192 | 76 | 4 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.24e-04 | 192 | 76 | 4 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 3.24e-04 | 192 | 76 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.24e-04 | 192 | 76 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-04 | 192 | 76 | 4 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.24e-04 | 192 | 76 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 3.24e-04 | 192 | 76 | 4 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 192 | 76 | 4 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 192 | 76 | 4 | 849ac3c115e6f913e68ca050c308bc4c32cf662b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-04 | 193 | 76 | 4 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.94e-05 | 49 | 49 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.17e-06 | 180 | 75 | 7 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.51e-06 | 184 | 75 | 7 | 2321_DN | |
| Drug | N-hydroxythalidomide | 1.07e-05 | 2 | 75 | 2 | CID000124398 | |
| Disease | Malignant neoplasm of breast | DPYD ATP7B DDX18 SETBP1 EFCAB13 NUP98 MACF1 HES1 BOD1L1 FSCB NIPBL TOP1 | 8.98e-06 | 1074 | 71 | 12 | C0006142 |
| Disease | unipolar depression, bipolar disorder | 3.81e-05 | 156 | 71 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Autism Spectrum Disorders | 5.38e-05 | 85 | 71 | 4 | C1510586 | |
| Disease | Neurodevelopmental Disorders | 7.64e-05 | 93 | 71 | 4 | C1535926 | |
| Disease | Intellectual Disability | 1.01e-04 | 447 | 71 | 7 | C3714756 | |
| Disease | Acute erythroleukemia - M6a subtype | 1.58e-04 | 8 | 71 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 1.58e-04 | 8 | 71 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 1.58e-04 | 8 | 71 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 1.58e-04 | 8 | 71 | 2 | C2930974 | |
| Disease | Cornelia De Lange Syndrome | 1.58e-04 | 8 | 71 | 2 | C0270972 | |
| Disease | Fuchs endothelial corneal dystrophy | 2.54e-04 | 10 | 71 | 2 | Orphanet_98974 | |
| Disease | Colorectal Carcinoma | 2.80e-04 | 702 | 71 | 8 | C0009402 | |
| Disease | Small cell carcinoma of lung | 3.03e-04 | 54 | 71 | 3 | C0149925 | |
| Disease | Semantic-Pragmatic Disorder | 3.10e-04 | 11 | 71 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 3.10e-04 | 11 | 71 | 2 | C0751257 | |
| Disease | Language Delay | 3.10e-04 | 11 | 71 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.10e-04 | 11 | 71 | 2 | C0023014 | |
| Disease | Macrocephaly | 3.10e-04 | 11 | 71 | 2 | C0221355 | |
| Disease | Speech Delay | 3.10e-04 | 11 | 71 | 2 | C0241210 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.71e-04 | 12 | 71 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in IDL percentage | 4.14e-04 | 60 | 71 | 3 | EFO_0022233 | |
| Disease | Colonic Neoplasms | 5.03e-04 | 152 | 71 | 4 | C0009375 | |
| Disease | Colorectal Neoplasms | 5.52e-04 | 277 | 71 | 5 | C0009404 | |
| Disease | common carotid intimal medial thickness | 5.73e-04 | 67 | 71 | 3 | EFO_0004860 | |
| Disease | Malignant tumor of colon | 5.96e-04 | 159 | 71 | 4 | C0007102 | |
| Disease | Leukemia, Myelocytic, Acute | 8.17e-04 | 173 | 71 | 4 | C0023467 | |
| Disease | body weight | DMTF1 DPYD TCF7L2 INTS12 PTPRG SETBP1 NUCKS1 MLLT3 CHD8 NIPBL | 8.45e-04 | 1261 | 71 | 10 | EFO_0004338 |
| Disease | Myeloid Leukemia | 8.52e-04 | 18 | 71 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 8.52e-04 | 18 | 71 | 2 | C0023466 | |
| Disease | apolipoprotein B measurement | 1.07e-03 | 663 | 71 | 7 | EFO_0004615 | |
| Disease | Neutropenia | 1.16e-03 | 21 | 71 | 2 | C0027947 | |
| Disease | grip strength measurement | 1.57e-03 | 350 | 71 | 5 | EFO_0006941 | |
| Disease | Micronuclei, Chromosome-Defective | 1.79e-03 | 26 | 71 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 1.79e-03 | 26 | 71 | 2 | C1449862 | |
| Disease | sleep duration | 1.81e-03 | 362 | 71 | 5 | EFO_0005271 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.86e-03 | 364 | 71 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | S-6-hydroxywarfarin measurement | 1.95e-03 | 368 | 71 | 5 | EFO_0803326 | |
| Disease | unipolar depression, irritable bowel syndrome | 2.07e-03 | 28 | 71 | 2 | EFO_0000555, EFO_0003761 | |
| Disease | platelet component distribution width | 2.25e-03 | 755 | 71 | 7 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDSEKKEKSGVTHAA | 601 | P23470 | |
| KKVKSQSTFDIHKAD | 1536 | Q9HCK8 | |
| DTKEKHKDTHGKDKE | 1061 | Q6UB99 | |
| HAAEDKAKSKHKEKS | 1246 | Q6UB99 | |
| HKEKSDKEHSKERKS | 1256 | Q6UB99 | |
| EHLAKSKTSEALAKL | 781 | P35670 | |
| KPSKDSREHKSAFKE | 206 | P42568 | |
| EKKETKEKSHLSTSE | 1591 | Q6RI45 | |
| ATLCSTSAKKLDKKH | 26 | Q12882 | |
| DSDDSSSEVKRKKHK | 131 | O14646 | |
| TTKEDKDSLTNKGHK | 136 | Q9Y222 | |
| KKAKKKASSSDSEDS | 76 | Q14978 | |
| SESSEDEKPTKKHKK | 146 | Q9Y388 | |
| EKDDTGPKKHSSKNS | 196 | Q9Y388 | |
| HSKSKDSAEKLKALL | 21 | Q96CB8 | |
| SEDKDVKTKKDDSHS | 61 | Q9H1E3 | |
| VKTKKDDSHSAEDSE | 66 | Q9H1E3 | |
| STSFKDEDKTAKLHH | 456 | Q8IYW4 | |
| ESSCESHRKSKKEKK | 176 | Q9BU76 | |
| EEEEHPSKTSTKKLK | 891 | P52948 | |
| SMHKKAKDSKNSSSA | 341 | Q5TC84 | |
| THESESESKESVKKK | 146 | Q8N9E0 | |
| KDGEDLKDHSTESKK | 146 | Q9UHB6 | |
| DSSSTKSKEDALKHK | 171 | Q5H9T9 | |
| SHEKSNKSLEDKSLE | 1191 | Q13439 | |
| SSSSKKDKTHVKMES | 226 | B7ZW38 | |
| KRKDKTKKDCEESSH | 231 | Q70Z53 | |
| TKKDCEESSHKKSRL | 236 | Q70Z53 | |
| SSAEEASKKKDKGHS | 251 | Q70Z53 | |
| DKGHSSSKKSEDSLL | 261 | Q70Z53 | |
| KESKSRTDLKEEHKS | 136 | Q9Y6V0 | |
| PLHEKEAKDDSKTKT | 276 | P29536 | |
| KPEVSKHKQDTKSDS | 776 | Q6KC79 | |
| IKSDSSKTDKLERKH | 856 | Q6KC79 | |
| SSSSKKDKTHVKMES | 226 | P0DMR1 | |
| DTDETSKKIAHAKAV | 2621 | O15230 | |
| KSKIFKHISKKSSDS | 651 | Q9NVP1 | |
| KKTFLAKDDHKESQE | 2236 | Q9UPN3 | |
| SKEKSKQLESKSNEH | 516 | Q13427 | |
| KTEKKFDHSKKSEDT | 341 | Q8NFC6 | |
| FDHSKKSEDTQKVKD | 346 | Q8NFC6 | |
| TLKNEKHLKKDDSET | 696 | Q8NFC6 | |
| KEKGKTAFSHSSEKH | 41 | Q96QU4 | |
| KEKGKTAFSHSSEKH | 41 | Q64ET8 | |
| SSKVLESSDHKLKKR | 486 | Q4AC94 | |
| SKETKSHKALSDLEL | 281 | Q9HB55 | |
| LKSKATEHATELAKE | 221 | Q5R3K3 | |
| PSTTKDKHKEEDKNS | 471 | Q9NYF8 | |
| ASVKKEDLKSKHDSS | 876 | Q9BTC0 | |
| FKKHSEKGEIHDSKS | 391 | Q8IY85 | |
| KSCKETFKEKHSSKS | 2431 | Q03164 | |
| SKDANKESSKTSKPH | 181 | Q03111 | |
| SSKSDEKKIKNTDKH | 886 | Q5T890 | |
| ASASKEKETSAEKSK | 1101 | Q9ULU4 | |
| SSKRKHKKYSEDSDS | 201 | Q8N5F7 | |
| HKSKEATPAKEKHSD | 241 | Q92833 | |
| KKDSSRHSKLEKADI | 66 | Q14469 | |
| KDKSSKKHKSEEHND | 76 | Q7L4I2 | |
| ATEKAKDLASKAATK | 196 | Q9Y255 | |
| DDAVTKADSHEKKPK | 746 | Q6Q759 | |
| KLAEKTRHFKSKTDS | 506 | A6NHY2 | |
| DKSKKRKLHEELSSS | 311 | Q86X95 | |
| HKTKDPKEKNTSSET | 961 | Q15021 | |
| NKKTKKESSDSSCKD | 241 | Q5M9Q1 | |
| KDNHEASTKKKPSSE | 501 | O75475 | |
| HKEMAKSKSKETTAT | 166 | Q15785 | |
| AAKKHSSSKDKSQLI | 426 | Q70EL2 | |
| KKKKHRDRKSSDSDS | 191 | Q9NP64 | |
| EKSKAKEQKHSDSGT | 1251 | Q7Z4S6 | |
| RASKELKEKLDSSHK | 321 | Q15413 | |
| EDDSHHKAEKSSVLK | 61 | Q14515 | |
| HKAEKSSVLKSKEES | 66 | Q14515 | |
| RSKEKSSKHKNESKE | 451 | Q5VTL8 | |
| HLNKTAESASSEKKK | 6 | Q9NPD5 | |
| NSELATEHKKELSKS | 131 | Q8NHR7 | |
| LHSSKHQDSKKEEEK | 331 | Q9NQB0 | |
| SKAESIDALSNKHSK | 711 | Q9UBT6 | |
| KKHRKSSSDSDDEEK | 506 | O95391 | |
| AKADTISKSELHKFK | 186 | Q92599 | |
| KSEEHADSKEHAKKT | 966 | P11137 | |
| DADDKHKLITKTEAK | 131 | P23025 | |
| KDDDSLSEASHSKKT | 66 | Q8NDX6 | |
| KNSKATKEEERSHSK | 146 | Q9Y6X0 | |
| KSKHSNSEHKDSEKK | 46 | P11387 | |
| HKEKEKTKHKDGSSE | 61 | P11387 | |
| KSEHETSDAKKSVED | 556 | P40818 | |
| KSHEETDSTKEEAAK | 361 | Q8WXD2 | |
| CSETKDSKKELDKHQ | 771 | Q9NUA8 | |
| SKLSTKDHKSEKDQA | 1546 | Q5VU43 |